Bone density, bone markers and bone radiological features in mastocytosis

Area of Science:

• Bone biology
• Hematology
• Endocrinology

Background:

• Systemic mastocytosis is a rare hematologic disorder characterized by mast cell infiltration.
• Skeletal manifestations, including osteoporosis, are common in systemic mastocytosis.
• The relationship between mastocytosis severity and bone health requires further elucidation.

Observation:

• Sixteen patients with varying mastocytosis severity, assessed by urine methylimidazoleacetic acid, were studied.
• Bone density, skeletal manifestations, and bone markers were evaluated.
• Both osteoporosis and osteosclerosis were observed in the patient cohort.

Findings:

• Increased hip bone density was observed in patients with higher histamine metabolite excretion.
• Patients with moderately increased mast cell mass exhibited low bone mineral density, osteoporosis, and vertebral fractures.
• Biologically active substances released by mast cells may influence osteoblast and osteoclast activity, leading to diverse skeletal patterns.

Implications:

• Understanding the link between mast cell mediators and bone metabolism is crucial for managing mastocytosis-related skeletal complications.
• Bisphosphonate therapy may be a potential treatment to mitigate osteoporosis in systemic mastocytosis.
• Further research into the specific mechanisms of mast cell mediators on bone cells can inform targeted therapeutic strategies.